Healthcare PE | Regulatory Enforcement

The Green Light Has a Yellow Sign

FTC Healthcare Task Force | March 2026

March 2026·Sarratt Global Advisors·Signal Note

On Friday afternoon, the FTC chair directed all five agency bureaus — Competition, Consumer Protection, Economics, Policy, and Technology — to form a single Healthcare Task Force. Most PE deal teams will read that as noise from a chairman they already understand. They understand Ferguson correctly. They're reading the announcement wrong.

Two years ago, the Biden FTC sued Welsh Carson — a private equity firm — as a named defendant in a healthcare antitrust case, arguing that the ownership structure itself was the violation. Ferguson's FTC rejected that theory on arrival. PE status is irrelevant to antitrust analysis; what matters is behavior. The deal teams who pocketed that shift were right to. But the task force isn't a return to the ownership theory. It's a structural upgrade to enforce the behavioral one — and simultaneously, seven states have been building a parallel enforcement architecture that PE healthcare deal teams are not tracking.

What Changed

Ferguson's FTC has been active for months. In March it settled with Express Scripts — one of the three largest pharmacy benefit managers, managing drug benefits for roughly 270 million Americans — requiring fundamental pricing practice changes across a $400B+ distribution network. In January it blocked a medical device acquisition. Since September it has sent noncompete warning letters to HCA Healthcare, Tenet Healthcare, and United Health Services.

What's new is coordination. The task force puts Competition and Consumer Protection in the same room, on the same targets, at the same time. An antitrust investigation into a physician roll-up and a consumer fraud investigation into its billing practices can now run in parallel. That capability did not exist before.

The second change isn't in the announcement. While federal enforcement shifted from ownership-as-target to behavior-as-target, states moved the other way. Seven states have enacted or are legislating sub-federal notification requirements that specifically target PE healthcare acquisitions below the federal $133.9M HSR threshold — the level where most add-on acquisitions occur. In February 2026 alone, PE firms completed 51 healthcare add-on acquisitions. In at least one state, most of those are now filing events.

Who's Exposed

Add-on pipelines in mini-HSR states

If you are closing healthcare acquisitions in California, Indiana, Colorado, Washington, or Illinois this year: the compliance map changed. California's OHCA is already reviewing transactions. Indiana's fine clock starts July 1 at $10,000/day for non-compliance.

Behavioral health platforms on Medicaid

This is where the two enforcement tracks converge most sharply. Private equity owns 85% of ABA therapy providers in the U.S. The OBBBA cuts $900B from Medicaid over ten years. In North Carolina alone, ABA therapy Medicaid costs have risen 423% since 2022. The behavioral response to margin compression — billing optimization, labor restructuring, add-on acquisition — is exactly what both the task force's Consumer Protection bureau and state AG offices were built to investigate.

Ferguson told you he's not Lina Khan. He didn't tell you the states aren't.

What We're Watching

DateEventStatus
Spring 2026California OHCA final regulations — scope of PE approval requirementPENDING
July 1, 2026Indiana mini-HSR effective date — $10K/day non-complianceCONFIRMED
90 daysFTC Task Force first enforcement action — defines behavioral theory targetsMONITORING
OngoingIllinois AG consent bill — full legislature voteMONITORING

The task force was announced Friday. Indiana's clock runs to July 1. If you have add-on acquisitions in flight in regulated healthcare markets, the state-by-state compliance map is a pre-LOI question, not a post-signing one.

How Sarratt Global Advisors Can Help

Pre-Investment Diligence. State-level enforcement exposure mapping, mini-HSR notification requirements, and FTC task force risk assessment for healthcare transactions before LOI.

Portfolio Company Support. Ongoing monitoring of task force enforcement activity, state AG actions, noncompete enforcement signals, and Medicaid reimbursement trajectory across PE-backed healthcare platforms.

Scenario Playbooks. What does the deal environment look like if Illinois's AG consent bill passes? If the task force's first action targets a behavioral health platform? We build the scenario maps before the market needs them.

Satish Narayanan | Managing Partner
satish@sarrattglobal.com | www.sarrattglobal.com

Connected Signals